D, D., V, S., A, J., A, J., & JL, W. (2025). Immunotherapy with low-dose IL-2 attenuates vascular injury in mice with diabetic and neovascular retinopathy by restoring the balance between Foxp3+ Tregs and CD8+ T cells. Diabetologia, 68(7), 1559. https://doi.org/10.1007/s00125-025-06412-8
Chicago Style (17th ed.) CitationD, Deliyanti, Suphapimol V, Joglekar A, Jayasimhan A, and Wilkinson-Berka JL. "Immunotherapy with Low-dose IL-2 Attenuates Vascular Injury in Mice with Diabetic and Neovascular Retinopathy by Restoring the Balance Between Foxp3+ Tregs and CD8+ T cells." Diabetologia 68, no. 7 (2025): 1559. https://doi.org/10.1007/s00125-025-06412-8.
MLA (9th ed.) CitationD, Deliyanti, et al. "Immunotherapy with Low-dose IL-2 Attenuates Vascular Injury in Mice with Diabetic and Neovascular Retinopathy by Restoring the Balance Between Foxp3+ Tregs and CD8+ T cells." Diabetologia, vol. 68, no. 7, 2025, p. 1559, https://doi.org/10.1007/s00125-025-06412-8.